Innovation Fund 2003 MAC Membership
Multidisciplinary Assessment Committee (MAC) Membership
Quality and experience are the CFI's prime considerations when it selects committee members. In addition, the CFI strives to achieve a reasonable balance in terms of language, gender, region, sector of the economy, field of study, and type of institution.
All MAC members and experts involved in the review sign a confidentiality agreement in which they agree not to discuss any aspect of any proposal with anyone outside the committee.
In addition, the CFI expects that members of the research community will not contact MAC members to obtain information on committee deliberations. Members are instructed not to enter into discussions of any kind - related to the review process or specific projects - with other members of the research community. The members will not receive additional information or representations relating to projects except where provided directly by the CFI. They will refer all inquiries, or other material directed to them personally, to CFI staff for response.
Committees will review applications on the basis of the three CFI Innovation Fund criteria: quality of the research and need for the infrastructure, contribution to strengthening the capacity for innovation, and potential benefits to Canada. Comments made on projects in previous CFI review processes will not be given to committees. This is a completely new review process.
Ten MACs composed of a chair plus 12 to 15 members with broad expertise in research, research management and the use of research results, will review a total of 486 proposals requesting approximately $1.2 billion from the CFI. They will meet on January 13, 14 & 15 2004 and make a recommendation to the CFI Board for each proposal.
On February 3, 2004, a SuperMAC committee will meet to review the recommendations of the MACs to ensure consistency. If the recommendations from the MACs exceed the budget available i.e. $450 million, this group will choose between projects of comparable merit that most effectively support the CFI’s mandate and research in Canada. The following strategic considerations will be taken into account:
- Transformative capacity of the research and its potential social and economic benefits to Canada
- Ability of the proposed infrastructure to serve the research communities in a region or across the country
- Distribution of projects among fields of research
- Institutional priorities or provincial priorities, where available
- Distribution of awards among institutions
Each Multidisciplinary Assessment Committee (MAC) will review applications from institutions in one of the three following categories:
- Category A: Degree granting institutions receiving more than 1% of federal granting agency funding ; hospitals; not-for profit organizations
- Category B: Degree-granting institutions receiving less than 1% of federal granting agency funding
- Category C: Colleges (do not confer degrees)
Brière, Denis
Faculté de foresterie et de géomatique
Université Laval
QUEBEC QC
Cannon, Elizabeth
Department Geomatics Engineering
University of Calgary
Calgary AB
Glavin, Gary
Scientific Director's Office and Administration
Health Canada
WINNIPEG MB
Kolb, Bryan
Psychology and Neuroscience/ Canadian Centre for Behavioural Neuroscience
University of Lethbridge
Lethbridge, AB
Legault, Albert
Département de science politique
Université du Québec à Montréal
MONTREAL QC
Simard, Jacques
Laboratoire de génomique des cancers - CHUL
Université Laval
Québec QC
Theriault, Elizabeth
Department of Foreign Affairs and International Trade
OTTAWA ON
Walzak, Tim
Innovation and Development Corportion (IDC)
University of Victoria
Victoria, BC
Williams, F. Mary
NRC Institute for Ocean Technogies
ST. JOHN'S NF
Worton, Ronald
Ottawa Health Research Institute
The Ottawa Hospital
OTTAWA ON
CHAIR:
Michael Gibbons
Secretary General
Association of Commonwealth Universities
MEMBERS:
Don Aitkin
Former Vice-Chancellor and President
University of Canberra
Former Founding Chairman
Australian Research Council
Doug Barber
A founder, retired President and CEO
Gennum Corp.
Daniel Bouthillier
Director, Research and Development
Merck Frosst Canada Ltd.
Carol Cass
Vice-President
Alberta Cancer Board
Director
Cross Cancer Institute
Penelope W. Codding
Associate Vice President Research
Canadian Institute for Advanced Research
Professor of Chemistry
University of Victoria
Kevin Keough
Chief Scientist, Health Canada
Ken Lawless
President and CEO / PDG
Ottawa Life Sciences Council
Camille Limoges
Research and Innovation Policy Consultant /
Consultant, Politique de recherche et d’innovation
